Rick Wise
Stock Analyst at Stifel
(4.33)
# 400
Out of 4,981 analysts
245
Total ratings
64.14%
Success rate
11.49%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Buy | $35 | $32.89 | +6.42% | 1 | Sep 2, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $9 → $6 | $7.22 | -16.90% | 9 | Aug 8, 2025 | |
| AORT Artivion | Maintains: Buy | $36 → $40 | $39.76 | +0.60% | 7 | Aug 8, 2025 | |
| BAX Baxter International | Downgrades: Hold | $36 → $25 | $23.80 | +5.04% | 9 | Aug 4, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $5 | $1.59 | +214.47% | 5 | Jul 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $90 → $95 | $76.05 | +24.92% | 24 | Jul 25, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $100.96 | +13.91% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $185.74 | +20.60% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $51.79 | +6.20% | 12 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $131.33 | +10.41% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $22.68 | +23.46% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $32 | $19.56 | +63.60% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $60 | $55.43 | +8.24% | 6 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $34.63 | +38.61% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $99.87 | +20.16% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $377.11 | +16.68% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $177.40 | -12.63% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $433.99 | +40.56% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $145.72 | +30.39% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $73.21 | +12.01% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $77.76 | +31.17% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $93.43 | -6.88% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $4.09 | +193.40% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $92.37 | -18.80% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $12.09 | +98.51% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $13.73 | +555.50% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.27 | +103.75% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $44.78 | +150.11% | 5 | Oct 2, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Buy
Price Target: $35
Current: $32.89
Upside: +6.42%
Treace Medical Concepts
Aug 8, 2025
Maintains: Hold
Price Target: $9 → $6
Current: $7.22
Upside: -16.90%
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $36 → $40
Current: $39.76
Upside: +0.60%
Baxter International
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $23.80
Upside: +5.04%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.59
Upside: +214.47%
Edwards Lifesciences
Jul 25, 2025
Maintains: Buy
Price Target: $90 → $95
Current: $76.05
Upside: +24.92%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $100.96
Upside: +13.91%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $185.74
Upside: +20.60%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $51.79
Upside: +6.20%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $131.33
Upside: +10.41%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.68
Upside: +23.46%
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $19.56
Upside: +63.60%
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $55.43
Upside: +8.24%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $34.63
Upside: +38.61%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $99.87
Upside: +20.16%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $377.11
Upside: +16.68%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $177.40
Upside: -12.63%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $433.99
Upside: +40.56%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $145.72
Upside: +30.39%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $73.21
Upside: +12.01%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $77.76
Upside: +31.17%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $93.43
Upside: -6.88%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $4.09
Upside: +193.40%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $92.37
Upside: -18.80%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $12.09
Upside: +98.51%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $13.73
Upside: +555.50%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.27
Upside: +103.75%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $44.78
Upside: +150.11%